CRGX
CARGO Therapeutics Inc

347
Loading...
Loading...
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
167

Frequently Asked Questions

What is Market Cap of CARGO Therapeutics Inc?
What is the 52-week high for CARGO Therapeutics Inc?
What is the 52-week low for CARGO Therapeutics Inc?
What is CARGO Therapeutics Inc stock price today?
What was CARGO Therapeutics Inc stock price yesterday?
What is the PE ratio of CARGO Therapeutics Inc?
What is the Price-to-Book ratio of CARGO Therapeutics Inc?
What is the 50-day moving average of CARGO Therapeutics Inc?
How many employess does CARGO Therapeutics Inc has?

Latest CRGX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.